Anna Zemczak

Tandem peptide receptor radionuclide therapy using 90Y/177Lu-DOTATATE for neuroendocrine tumors efficacy and side-effects - polish multicenter experience

Jolanta Kunikowska, Anna Zemczak, Maciej Kołodziej et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 54 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

The value of the Ki-67 proliferation marker as a prognostic factor in gastroenteropancreatic neuroendocrine tumours.

Wanda Fołtyn, Wojciech Zajęcki, Bogdan Marek et al. · PubMed · 2012 · 43 citations

Medicine, Oncology, Pathology +17

The relation of serum adiponectin and leptin levels to metabolic syndrome in women before and after the menopause.

Lucyna Siemińśka, Celina Wojciechowska, Wanda Fołtyn et al. · PubMed · 2006 · 29 citations

Medicine, Endocrinology, Metabolic Physiology +14

Acute phase proteins: C-reactive protein and fibrinogen in young women with polycystic ovary syndrome

Maja Nasiek, Beata Kos‐Kudła, Zofia Ostrowska et al. · Pathophysiology · 2006 · 28 citations · Full text

Medicine, Endocrinology, Gynecology +14

The Safety and Efficacy of the Repeated PRRT with [90Y]Y/[177Lu]Lu-DOTATATE in Patients with NET

Anna Zemczak, Paweł Gut, Dariusz Pawlak et al. · International Journal of Endocrinology · 2021 · 21 citations · Full text

Medicine, Nuclear Medicine, Oncology +17